Cytec India Specialty Chemicals & Materials Profile
Key Indicators
- Authorised Capital ₹ 322.96 Cr
as on 04-05-2024
- Paid Up Capital ₹ 322.96 Cr
as on 04-05-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -93.56%
(FY 2017)
- Profit 86.12%
(FY 2017)
- Ebitda 80.50%
(FY 2017)
- Net Worth -13.93%
(FY 2017)
- Total Assets -64.67%
(FY 2017)
About Cytec India Specialty Chemicals & Materials
- CIN/LLPIN
U24233MH2012PTC225865
- Company No.
225865
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cytec India Specialty Chemicals & Materials?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Mishra  | Director | 04-May-2021 | Current |
| Mukesh Malhotra | Director | 03-Aug-2017 | Current |
Lim Swee  | Director | 09-Jan-2012 | Current |
Financial Performance of Cytec India Specialty Chemicals & Materials.
Cytec India Specialty Chemicals & Materials Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 93.56% decrease. The company also saw a substantial improvement in profitability, with a 86.12% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cytec India Specialty Chemicals & Materials?
In 2017, Cytec India Specialty Chemicals & Materials had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Solvay Specialities India Private LimitedActive 19 years 6 monthsMukesh Malhotra and Neeraj Mishra are mutual person
Catasynth Speciality Chemicals Private LimitedActive 8 years 11 monthsMukesh Malhotra is a mutual person
Hindustan Gum And Chemicals LimitedActive 62 years 10 monthsMukesh Malhotra and Neeraj Mishra are mutual person
Indo-Belgian Luxembourg Chamber Of Commerce And IndustryActive 23 years 5 monthsMukesh Malhotra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cytec India Specialty Chemicals & Materials?
Unlock and access historical data on people associated with Cytec India Specialty Chemicals & Materials, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cytec India Specialty Chemicals & Materials, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytec India Specialty Chemicals & Materials's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
